nir-vana innovation network

The product is a treatment in the form of a gelling fiber dressing. It disrupts bacterial and yeast (candida) biofilms, has a long-lasting antimicrobial effect and at the same time is highly absorbent for treating highly exuding wounds. It outperforms leading silver dressings in tests on fibroblast cells, showing significantly reduced local toxicity, creating a unique combination. The company are working with respected independent labs and universities on these tests to build a strong research base for the product.
The active component is an iodophor (iodine compound). Iodophors have been identified as the most effective agents tested against biofilms in wounds. They have filed several patents covering the technology. The dressing is manufactured in a range of sizes, to match the existing widely-used dressings in this field.
The company are a small UK based, dedicated to wound care and founded on expertise from long experience in blue chip companies in the field. They are looking to partner with US distributers via a distribution services agreeement

Advantages & innovations

They have tested the concept with US nurses and wound care center nurse administrators. The unique combination of antimicrobial, anti-biofilm and fluid handling properties were desirable, especially as it provides an alternative to silver dressings. They rated it especially high for likelihood to advocate for including the dressing in their facility. “It’s targeting the three things that are incredibly important in wound management” Customers commented that this product has the potential to keep the wound bed in a clean, healing state between debridement sessions. Advantages are: 1. Combine anti-biofilm and high absorbency with improved host cell response for healing. 2. No need for separate anti-biofilm treatment, it is part of the dressing 3. The combination is capable of extending the benefits of debridement as part of gold standard care 4. No silver, avoiding clinician concerns about over-use of silver 5. Patents filed to protect the design

Stage of development

Available for demonstration

Partner sought

The company are small UK based, dedicated to wound care and founded on expertise from long experience in blue chip companies in this field of health care. They are looking to partner with US distributers who have experience and have a portfolio of products that would be complimentary to this product and could add vaue. This is envisiaged to be via a distribution services agreement